0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Back Home

biosciences/Wellcome Open Res


37 results

Pf8: an open dataset of Plasmodium falciparum genome variation in 33,325 worldwide samples.Malaria Genomic Epidemiology Network Abdel Hamid MM Abdelraheem MH Acheampong DO Adam I Aide P Ajibaye O Ali M Almagro-Garcia J Amambua-Ngwa A Amenga-Etego L Aniebo I Aninagyei E Ansah F Apinjoh TO Ariani CV Auburn S Awandare GA Balmer A Bejon P Boene S Bwire G Candrinho B Chidimatembue A Chindavongsa K Comiche K Conway D Dara A Diakite M Djimde A Dondorp A Doumbia S Drury E Fanello CA Ferdig M Figueroa K Gamboa D Golassa L Goncalves S Guindo MDA Hamaluba M Hanboonkunupakarn B Howe K Hussien M Imwong M Ishengoma D Jeans J Kabaghe A Kamuhabwa A Kindermans JM Konate DS Kwiatkowski DP Lee C Lee SK Lee SJ Ley B Llanos-Cuentas A Marfurt J Matambisso G Maude RR Maude RJ Mayor A Mayxay M Maiga-Ascofare O McCann RS Miles A Miotto O Mohamed AO Morang'a CM Murie K Ngasala BE Nguyen TN Nolasco O Nosten F Noviyanti R O'Connor I Oboh M Ochola-Oyier LI Olufunke Falade C Olukosi A Olumide A Olusola FI Onyamboko MA Oriero EC Oyibo WA Pannebaker D Pearson RD Phiri K van der Pluijm RW Price RN Quang HH Rajkumar Devaraju V Randrianarivelojosia M Ranford-Cartwright L Rayner JC Rovira-Vallbona E Rowlands K Ruano-Rubio V Sanchez JF Saute F Shettima S da Silva C Simpson VJ Suddaby S Takken W Thu AM Toure M Unlu E Valdivia HO van Vugt M Waithira N Wellems T Wendler J White N Wuendrich Ogidan R
Wellcome Open Res, (2025). 10:325

A pragmatic randomized controlled trial of standard care versus corticosteroids plus standard care for treatment of pneumonia in adults admitted to Kenyan hospitals (SONIA).Lucinde R Abdi A Orindi B Mwakio S Gathuri H Onyango E Chira S Ogero M Isaaka L Shangala J Oginga IN Wachira A Manuthu E Kariuki H Nyikuli J Wekesa C Otedo A Bosire H Okoth SB Ongalo W Mukabi D Lusamba W Muthui B Kirui N Adembesa I Mithi C Sood M Ahmed N Gituma B Ongaki VB Giabe M Omondi C Ombajo LA Kagucia W English M Hamaluba M Ochola-Oyier LI Kamuya D Bejon P Agweyu A Akech S Etyang AO
Wellcome Open Res, (2025). 7:269

Identification of coxsackievirus A24 variant during an acute hemorrhagic conjunctivitis outbreak in coastal Kenya, 2024.Lambisia AW Mwita Morobe J Moraa E Mwarumba S Korir FKN Seif Athman R Kiptui R Mbee M Mugo N Amoth P Muange P JHouldcroft C Barasa E Mwangangi J Githinji G CHolmes E Ochola-Oyier LI Agoti CN
Wellcome Open Res, (2025). 10:28

Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study.Kimotho J Sein Y Sayed S Shah R Mwai K Saleh M Wanjiku P Mwacharo J Nyagwange J Karanja H Kutima B Gitonga JN Mugo D Karanu A Moranga L Oluoch V Shah J Mutiso J Mburu A Nneka Z Betti P Usyu Mutinda W Abdi AI Bejon P Ochola-Oyier LI Warimwe GM Nduati EW Ndungu FM
Wellcome Open Res, (2025). 8:350

Comparative performance of the InBios SCoV-2 Detect (TM) IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations.Kutima B Kagucia EW Mwai K Kimani M Sigilai A Mugo D Karanja H Gitonga JN Karani A Akech D Toroitich M Karia B Tuju J Ziraba AK Bigogo G Ochieng C Onyango C Lidechi S Munywoki PK Uyoga S Adetifa IMO Oyier LIO Bejon P Scott JAG Agweyu A Warimwe GM Nyagwange J Kenya Sars-CoV-Serology Consortium
Wellcome Open Res, (2024). 9:349

A cross-sectional analysis identifies a low prevalence of Plasmodium ovale species infections in symptomatic and asymptomatic individuals in Kilifi county, Kenya.Akinyi MY Chifwete M Ndwiga L Kimenyi KM Osoti V Ochola-Oyier LI
Wellcome Open Res, (2024). 7:207

Utility of MALDI-TOF MS for determination of species identity and blood meal sources of primary malaria vectors on the Kenyan coast.Karisa J Ominde K Tuwei M Bartilol B Ondieki Z Musani H Wanjiku C Mwikali K Babu L Rono M Eminov M Mbogo C Bejon P Mwangangi J Laroche M Maia M
Wellcome Open Res, (2024). 8:151

Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial.Wamae K Ndwiga L Kharabora O Kimenyi K Osoti V de Laurent Z Wambua J Musyoki J Ngetsa C Kalume P Mwambingu G Hamaluba M van der Pluijm R Dondorp AM Bailey J Juliano J Bejon P Ochola-Oyier L
Wellcome Open Res, (2024). 7:95

Safety and immunogenicity of varied doses of R21/Matrix-M vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-Kenya.Sang S Datoo MS Otieno E Muiruri C Bellamy D Gathuri E Ngoto O Musembi J Provstgaard-Morys S Stockdale L Aboagye J Woods D Lawrie A Roberts R Keter K Kimani D Ndungu F Kapulu M Njau I Orindi B Ewer KJ Hill AVS Bejon P Hamaluba M
Wellcome Open Res, (2023). 8:450

Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.Hamaluba M Sang S Orindi B Njau I Karanja H Kamau N Gitonga JN Mugo D Wright D Nyagwange J Kutima B Omuoyo D Mwatasa M Ngetsa C Agoti C Cheruiyot S Nyaguara A Munene M Mturi N Oloo E Ochola-Oyier L Mumba N Mauncho C Namayi R Davies A Tsofa B Nduati EW Aliyan N Kasera K Etyang A Boyd A Hill A Gilbert S Douglas A Pollard A Bejon P Lambe T Warimwe G COVVaccine Trial Group
Wellcome Open Res, (2023). 8:182

Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples.MalariaGen, Abdel Hamid MM Abdelraheem MH Acheampong DO Ahouidi A Ali M Almagro-Garcia J Amambua-Ngwa A Amaratunga C Amenga-Etego L Andagalu B Anderson T Andrianaranjaka V Aniebo I Aninagyei E Ansah F Ansah PO Apinjoh T Arnaldo P Ashley E Auburn S Awandare GA Ba H Baraka V Barry A Bejon P Bertin GI Boni MF Borrmann S Bousema T Bouyou-Akotet M Branch O Bull PC Cheah H Chindavongsa K Chookajorn T Chotivanich K Claessens A Conway DJ Corredor V Courtier E Craig A D'Alessandro U Dama S Day N Denis B Dhorda M Diakite M Djimde A Dolecek C Dondorp A Doumbia S Drakeley C Drury E Duffy P Echeverry DF Egwang TG Enosse SMM Erko B Fairhurst RM Faiz A Fanello CA Fleharty M Forbes M Fukuda M Gamboa D Ghansah A Golassa L Goncalves S Harrison GLA Healy SA Hendry JA Hernandez-Koutoucheva A Hien TT Hill CA Hombhanje F Hott A Htut Y Hussein M Imwong M Ishengoma D Jackson SA Jacob CG Jeans J Johnson KJ Kamaliddin C Kamau E Keatley J Kochakarn T Konate DS Konate A Kone A Kwiatkowski DP Kyaw MP Kyle D Lawniczak M Lee SK Lemnge M Lim P Lon C Loua KM Mandara CI Marfurt J Marsh K Maude RJ Mayxay M Maiga-Ascofare O Miotto O Mita T Mobegi V Mohamed AO Mokuolu OA Montgomery J Morang'a CM Mueller I Murie K Newton PN Ngo Duc T Nguyen T Nguyen TN Nguyen Thi Kim T Nguyen Van H Noedl H Nosten F Noviyanti R Ntui VN Nzila A Ochola-Oyier LI Ocholla H Oduro A Omedo I Onyamboko MA Ouedraogo JB Oyebola K Oyibo WA Pearson R Peshu N Phyo AP Plowe CV Price RN Pukrittayakamee S Quang HH Randrianarivelojosia M Rayner JC Ringwald P Rosanas-Urgell A Rovira-Vallbona E Ruano-Rubio V Ruiz L Saunders D Shayo A Siba P Simpson VJ Sissoko MS Smith C Su XZ Sutherland C Takala-Harrison S Talman A Tavul L Thanh NV Thathy V Thu AM Toure M Tshefu A Verra F Vinetz J Wellems TE Wendler J White NJ Whitton G Yavo W van der Pluijm RW
Wellcome Open Res, (2023). 8:22

The CINAMR (Clinical Information Network-Antimicrobial Resistance) Project: A pilot microbial surveillance using hospitals linked to regional laboratories in Kenya: Study Protocol.Akech S Nyamwaya B Gachoki J Ogero M Kigo J Maina M Mutua E Ooko E Bejon P Mwarumba S Bahati F Mvera B Musyimi R Onsare R Hutter J Tanui E Wesangula E Turner P Dunachie S Lucey O McKnight J Cinamr Investigators
Wellcome Open Res, (2022). 7:256

Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data.Ojal J Brand SPC Were V Okiro EA Kombe IK Mburu C Aziza R Ogero M Agweyu A Warimwe GM Uyoga S Adetifa IMO Scott JAG Otieno E Ochola-Oyier LI Agoti CN Kasera K Amoth P Mwangangi M Aman R Ng'ang'a W Tsofa B Bejon P Barasa E Keeling MJ Nokes DJ
Wellcome Open Res, (2022). 6:127

Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya.Nyagwange J Ndwiga L Muteru K Wamae K Tuju J Testing Team C Kutima B Gitonga J Karanja H Mugo D Kasera K Amoth P Murunga N Babu L Otieno E Githinji G Nokes DJ Tsofa B Orindi B Barasa E Warimwe G Agoti CN Bejon P Ochola-Oyier LI
Wellcome Open Res, (2022). 7:69

TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults).Abouyannis M FitzGerald R Ngama M Mwangudzah H Nyambura YK Ngome S Riako D Babu L Lewa F Else L Dily Penchala S Orindi B Mumba N Kalama B Ndungu FM Adetifa I Khoo S Lalloo DG Casewell NR Hamaluba M
Wellcome Open Res, (2022). 7:90

10-year longitudinal study of malaria in children: Insights into acquisition and maintenance of naturally acquired immunity.Addy JWG Bediako Y Ndungu FM Valetta JJ Reid AJ Mwacharo J Ngoi JM Wambua J Otieno E Musyoki J Said K Berriman M Marsh K Bejon P Recker M Langhorne J
Wellcome Open Res, (2022). 6:79

Mortality in rural coastal Kenya measured using the Kilifi Health and Demographic Surveillance System: a 16-year descriptive analysis.Otiende M Bauni E Nyaguara A Amadi D Nyundo C Tsory E Walumbe D Kinuthia M Kihuha N Kahindi M Nyutu G Moisi J Deribew A Agweyu A Marsh K Tsofa B Bejon P Bottomley C Williams TN Scott JAG
Wellcome Open Res, (2021). 6:327

Equity for excellence in academic institutions: a manifesto for change.Wedekind L Noe A Mokaya J Tamandjou C Kapulu M Ruecker A Kestelyn E Zimba M Khatamzas E Eziefula AC Mackintosh CL Nascimento R Ariana P Best D Gibbs E Dunachie S Hadley G Ravenswood H Young B Kamau C Marsh K McShane H Hale R McPhilbin E Ovseiko PV Oxford Equity in Academia consortium Surender R Worland C White LJ Matthews PC
Wellcome Open Res, (2021). 6:142

An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples.MalariaGen, Ahouidi A Ali M Almagro-Garcia J Amambua-Ngwa A Amaratunga C Amato R Amenga-Etego L Andagalu B Anderson TJC Andrianaranjaka V Apinjoh T Ariani C Ashley EA Auburn S Awandare GA Ba H Baraka V Barry AE Bejon P Bertin GI Boni MF Borrmann S Bousema T Branch O Bull PC Busby GBJ Chookajorn T Chotivanich K Claessens A Conway D Craig A D'Alessandro U Dama S Day NP Denis B Diakite M Djimde A Dolecek C Dondorp AM Drakeley C Drury E Duffy P Echeverry DF Egwang TG Erko B Fairhurst RM Faiz A Fanello CA Fukuda MM Gamboa D Ghansah A Golassa L Goncalves S Hamilton WL Harrison GLA Hart L Henrichs C Hien TT Hill CA Hodgson A Hubbart C Imwong M Ishengoma DS Jackson SA Jacob CG Jeffery B Jeffreys AE Johnson KJ Jyothi D Kamaliddin C Kamau E Kekre M Kluczynski K Kochakarn T Konate A Kwiatkowski DP Kyaw MP Lim P Lon C Loua KM Maiga-Ascofare O Malangone C Manske M Marfurt J Marsh K Mayxay M Miles A Miotto O Mobegi V Mokuolu OA Montgomery J Mueller I Newton PN Nguyen T Nguyen TN Noedl H Nosten F Noviyanti R Nzila A Ochola-Oyier LI Ocholla H Oduro A Omedo I Onyamboko MA Ouedraogo JB Oyebola K Pearson RD Peshu N Phyo AP Plowe CV Price RN Pukrittayakamee S Randrianarivelojosia M Rayner JC Ringwald P Rockett KA Rowlands K Ruiz L Saunders D Shayo A Siba P Simpson VJ Stalker J Su XZ Sutherland C Takala-Harrison S Tavul L Thathy V Tshefu A Verra F Vinetz J Wellems TE Wendler J White NJ Wright I Yavo W Ye H
Wellcome Open Res, (2021). 6:42

Engagement of ethics and regulatory authorities on human infection studies: Proceedings of an engagement workshop in Zambia.Kunda-Ng'andu EM Simuyandi M Kapulu M Chirwa-Chobe M Mwanyungwi-Chinganya H Mwale S Chilengi R Sharma A
Wellcome Open Res, (2021). 6:31